Tag Archives: HEA

South Korea’s KT Develops AI-Based COVID-19 Research

– Korean Telecom Leader’s Proposal Accepted by Global Research Fund –

– KT’s AI, Big Data and Medical Resources Enhances Risk Assessment –

– New Project to Help KT Develop Global Epidemic Prevention Platform –

SEOUL, South Korea, Aug. 20, 2020 — KT Corp. (KRX: 030200; NYSE: KT), South Korea’s largest telecommunications company, is developing a COVID-19 infection risk assessment model, using its artificial intelligence (AI) and Big Data-based digital contact tracing technology, adding to global efforts to tackle the escalating pandemic.

The Korean telecom leader’s new pilot project is supported by the Research Investment for Global Health Technology Fund, better known as RIGHT Fund. The global research fund accepted the promising proposal by KT to develop AI-based technology that assesses COVID-19 infection risks.

"KT’s new project will help combat the pandemic globally," said Kim Chae-Hee, head of KT’s AI/Big Data division. "We at KT will do our best to help prevent COVID-19 from further spreading and raise the efficacy of medical service, using our AI and Big Data technologies for the sake of humanity."

KT plans to use the pilot project results to apply for a larger-scale, RIGHT Fund-supported project in 2021. RIGHT Fund is a global health research funding agency established in 2018 with contributions from Korea’s Ministry of Health and Welfare, the Bill & Melinda Gates Foundation and Korean life science companies to promote global public health.

For the pilot project, KT plans to assess COVID-19 infection risks by using AI and Big Data to analyze data on the movement of smartphone users and those who have been tested positive for COVID-19 and made public by the government.

"KT’s project will help developing countries, which are faced with shortages of medical resource, prevent the pandemic from spreading and conduct appropriate examinations and treatments," said Kim Youn-Been, CEO of the RIGHT Fund. "We hope that the project, taking advantage of Korea’s advanced expertise in ICT, will be carried out successfully to support developing countries in preventing, treating and managing the COVID-19 pandemic."

Mobile Doctor Corp. is also participating in this project, which is scheduled to end in February 2021. Both KT and Mobile Doctor, a provider of data-based platforms and solutions for health management, are members of a consortium conducting "A Next Generation Surveillance Study for Epidemic Preparedness," a three-year research program financed by the Bill & Melinda Gates Foundation.

KT expects the assessment model, based on identification of those who have been exposed to carriers of the novel coronavirus directly and indirectly, will help prevent further transmission of the COVID-19 pandemic while minimizing the risk of personal information leakage.

Korea’s top telecom company also looks forward to acquiring the capabilities to identify vulnerable high-risk groups in case of a second wave of the pandemic or group infections, and promote an effective use of limited medical resources, such as medical personnel and test kits.

Through the research, KT plans to further upgrade its Global Epidemic Prevention Platform (GEPP), focusing on providing information on infection risks of contagious diseases and digital contact tracing. GEPP uses Big Data and social media to give updates to travelers going to countries hit by epidemics and to track the movement of infected individuals.

At the same time, KT will help reduce the gap in the provision of medical service among different regions and different income groups in underdeveloped countries, using its information communication technology and digital capacity for research and development on health.

Eight South Korean life science companies donated to the RIGHT Fund. The fund is dedicated to addressing inequalities in health between regions and income groups around the world, through research and development for vaccines, therapeutics, diagnostics and digital health technologies, taking advantage of Korea’s advanced R&D capabilities.

##### End #####

MEDIA CONTACTS

For inquiries, please contact our Foreign Media Relations Team at kt.fmrt@gmail.com

ABOUT KT CORPORATION (KRX: 030200; NYSE: KT)

KT Corp., Korea’s largest telecommunications service provider, reestablished in 1981 under the Telecommunications Business Act, is leading the era of innovations in the world’s most connected country. The company is leading the 4th industrial revolution with high speed wire/wireless network and new ICT technology. KT launched the world’s first nationwide commercial 5G network on April 3, 2019, after successfully showcasing the world’s first trial 5G services at the PyeongChang Winter Olympic Games in February 2018. This is another milestone in KT’s continuous efforts to deliver essential products and services as it aspires to be the number one ICT Company and People’s Company.

For more information, please visit our English website at https://corp.kt.com/eng/

Related Links :

https://corp.kt.com/eng/

Hong Kong’s Hang Fook Elderly Home Adopts iBonus(R) Digital Prevention System Aimed at Helping Guard Against COVID-19

The new iBonus® Digital Prevention System is being adopted by a growing number of businesses, companies, and other entities in Hong Kong in an effort to help break COVID-19 transmission chains.

HONG KONG, Aug. 20, 2020 — One of the key reasons that COVID-19 has caused a great concern is its long incubation period. Most experts agree that for up to 14 days many affected patients have no obvious symptoms. Since nobody knows where these people have been or who they have been in contact with in the incubation period, many people around them could potentially also be infected, leading to eruptions of infection in communities and large numbers of new cases. Masks and glove can help stop this but there is clearly a demand for other safeguards as well. To help solve this problem, Hong Kong technology company iBonus Limited has launched a digital prevention system that records the times and places participants have visited through employee smart cards, or the Octopus transit card and a set of designated terminals installed at different locations.

Once someone’s infection has been confirmed, the system will immediately enter all persons who have appeared at the same times and places with the confirmed patient in the past 14 days into an alert list and the list will be sent to all terminals. When someone on the list enters an area, the terminal at that area will ring an alarm.

"COVID-19 has scared so many people because confirmed patients show no obvious symptoms during the incubation period," commented Keith, Managing Director of iBonus Limited. "As a result, they move around in the community like invisible people. If a system can track these patients as well as those in close contacts with them during the incubation period and restrict them from entering high-risk venues such as fresh markets, the elderly homes, hotpot and other restaurants, it can help to cut the chain of transmission and, we hope, put the pandemic under greater control."

The company understands that other kinds of technology working in this area, like contact trackers, have created understandable privacy concerns. Keith suggests the situation is different for this system as it only records the Octopus serial number, which is different from the real-name health code operation number recorded by competitors. By not attaching a real-name to the Octopus serial number it ensures there is no violation to participants’ privacy.

Currently, Hang Fook Elderly Home, Warwick Hotel, On Tai Fresh Market have adopted this system. iBonus is also in negotiation with many large restaurants and malls to also come onboard. Expect more news regarding these developments soon.

For more information be sure to visit https://covid2019system.com.

About iBonus Limited

iBonus Limited was incorporated on 9 June 2014. The iBonus® Legacy system is a contactless smartcard-based pre-paid offline system similar to the Hong Kong Octopus system.

Media Contact

Ms. Anna Lee
Telephone: (852) 91501890
Email: anna@iBonus.net 

Aon urges the re/insurance industry to bring capital closer to clients’ needs as the firm launches its Virtual Reinsurance Renewal Season


Virtual event launches with former Danish Prime Minister Helle Thorning-Schmidt interview

LONDON, Aug. 18, 2020 — Aon plc (NYSE: AON), a leading global professional services firm providing a broad range of risk, retirement and health solutions, today launches its Virtual Reinsurance Renewal Season, calling for the re/insurance industry to collaborate to bring capital closer to clients’ needs and drive growth across the global insurance ecosystem.

Andy Marcell, CEO of Aon’s Reinsurance Solutions business, said: "In an uncertain global economy, one thing is clear – reinsurance has never been more important as a strategic tool for client success. We are committed to collaborating with insurers and markets towards the 1st January renewals to help clients protect people and assets, strengthen their balance sheets and make better business decisions that reduce volatility."

While many of Aon’s insurer clients will continue to interact with broking, analytics and claims teams through virtual meetings, Aon’s Virtual Reinsurance Renewal Season platform aims to capture the conference experience with:

  • latest insights on market dynamics and the impact of the novel coronavirus (COVID-19) pandemic
  • innovation labs
  • newsroom
  • fireside chats with C-Suite leaders

Andy Marcell added: "The goal of the fireside chats is to drive growth across the re/insurance industry in order to bring capital closer to clients’ needs and enable them to flourish in a stronger economy." Hosted by Aon CEO Greg Case, Aon President Eric Andersen, Global Chairman of Aon’s Reinsurance Solutions business Dominic Christian, and Andy Marcell, the series will discuss the challenges and opportunities facing major re/insurers and insurance buyers, sharing both perspectives.  

The guests for the fireside chats include:

  • Helle Thorning-Schmidt, former Danish Prime Minister and Andy Marcell, Aon – 2nd September
  • Moses Ojeisekhoba, Swiss Re and Andy Marcell, Aon – 17th September
  • John Keogh, Chubb and Eric Andersen, Aon – 30th September
  • John Neal, Lloyd’s and Dominic Christian, Aon – 7th October
  • Franz Hahn, Peak Re and Dominic Christian, Aon – 13th October
  • Steve Wilder, Disney and Andy Marcell, Aon – 21st October
  • Thomas Buberl, AXA and Greg Case, Aon – 28th October
  • Richie Whitt, Markel and Andy Marcell, Aon – 4th November

About Aon
Aon plc (NYSE: AON) is a leading global professional services firm providing a broad range of risk, retirement and health solutions. Our 50,000 colleagues in 120 countries empower results for clients by using proprietary data and analytics to deliver insights that reduce volatility and improve performance.

Follow Aon on Twitter and LinkedIn 
Stay up to date by visiting the Aon Newsroom and hear from Aon’s expert advisors in The One Brief.
Sign up for News Alerts here     

Media Contacts
Alexandra Lewis
+44 (0) 207 086 0541
alexandra.lewis@aon.com  

Andrew Wragg
+44 (0)207 522 8183
andrew.wragg@aon.com 

David Bogg
+44 (0) 207 522 4016 
david.bogg@aon.com

Logo – https://techent.tv/wp-content/uploads/2020/08/aon-urges-the-re-insurance-industry-to-bring-capital-closer-to-clients-needs-as-the-firm-launches-its-virtual-reinsurance-renewal-season.jpg

Related Links :

http://www.aon.com

Sai Life Sciences opens new, state-of-the-art Research & Technology Centre in Hyderabad

– Completes first phase in committed investment of US$ 150M (> INR 1000 Cr)

– Sri KT Rama Rao, Hon’ble Minister for Industry & Commerce and IT, Government of Telangana inaugurates the facility

HYDERABAD, India, Aug. 17, 2020 — Sai Life Sciences, one of India’s fastest growing Contract Development & Manufacturing Organizations (CDMOs), today announced the inauguration of its new Research and Technology (R&T) Centre in Hyderabad, India. Sri K T Rama Rao, Hon’ble Minister for Industry & Commerce and IT, Government of Telangana formally inaugurated the facility in the presence of other dignitaries.

Sai Life Sciences New Research & Technology Centre
Sai Life Sciences New Research & Technology Centre

Speaking on the occasion, Sri KT Rama Rao said, "I’m very happy that the esteemed leadership of Sai Life sciences has considered Telangana for setting up their new R&D centre. Life Sciences is one of the key focus sectors for the Government of Telangana. Hyderabad serves more than 1000 global innovators in their vision to develop innovative and affordable medicines for the world. I sincerely congratulate the entire team of Sai Life Sciences, not only for the new Research & Technology Centre but, also for their work towards the development and manufacturing of new life saving medicines."

Built with an aspiration to achieve the best global benchmarks in lab infrastructure, the new R&T facility has several unique aspects such as intelligent & ergonomic lab design to enhance safety and productivity, advanced automation for seamless data capture during process development, lean & 5S approach to enhance productivity and collaborative workspaces for engendering innovation.

Making the announcement, Krishna Kanumuri, CEO & Managing Director of Sai Life Sciences said, "Our philosophy behind building this new facility was to go beyond what the norm is in India and to create what our global innovator partners expect in their inhouse capabilities." He further added, "We are an example of what is possible in Hyderabad’s rich life sciences ecosystem. Today, as we build world class R&D capabilities and invest in nurturing talent with deep domain expertise, I can unhesitatingly say, Hyderabad is truly a city where pharma dreams are made."

The new 83,000 sq.ft. (7700 sq.m.) facility houses state-of-the-art research capabilities and advanced technology platforms, augmenting the company’s capabilities in providing superior scientific solutions to its pharma and biotech innovator customers globally. It has 24 chemistry labs with 250 fume hoods, analytical labs, fully equipped technology suite and a dedicated process safety lab.

Sai Life Sciences began a process of organizational transformation in 2019 reinventing itself as a new generation global CDMO. Through this initiative, named Sai Nxt, the company is investing over US$ 150M (> INR 1000 Cr) to expand and upgrade its R&D and manufacturing facilities, induct top-notch global scientific and leadership talent, strengthen automation and data systems, and above all raise the bar for safety, quality and customer focus.

About Sai Life Sciences
Sai Life Sciences is a full-service CDMO driven by a vision to support the launch of 25 new medicines by 2025.  It works with innovator pharma and biotech companies globally, accelerating the discovery, development and manufacture of complex small molecules. A pure-play CDMO, Sai Life Sciences has served a diverse set of NCE development programs, consistently delivering value based on its quality and responsiveness. Today, it works with 7 of the top 10 large pharma companies, as well as several small and mid-sized pharma & biotech companies. Sai Life Sciences is privately held and backed by global investors, TPG Capital and HBM Healthcare Investments. https://www.sailife.com/

Photo: https://techent.tv/wp-content/uploads/2020/08/sai-life-sciences-opens-new-state-of-the-art-research-technology-centre-in-hyderabad-3.jpg  
Photo: https://techent.tv/wp-content/uploads/2020/08/sai-life-sciences-opens-new-state-of-the-art-research-technology-centre-in-hyderabad.jpg  
Logo: https://techent.tv/wp-content/uploads/2020/08/sai-life-sciences-opens-new-state-of-the-art-research-technology-centre-in-hyderabad-2.jpg

Inauguration of Sai Life Sciences’ New Research & Technology Centre. Seen in the picture from left to right – Krishna Kanumuri, CEO & MD Sai Life Sciences, Sri K T Rama Rao, Hon'ble Minister for IT, Industries, MA & UD and Jayesh Ranjan, Principal Secretary to Government Industries and Commerce
Inauguration of Sai Life Sciences’ New Research & Technology Centre. Seen in the picture from left to right – Krishna Kanumuri, CEO & MD Sai Life Sciences, Sri K T Rama Rao, Hon’ble Minister for IT, Industries, MA & UD and Jayesh Ranjan, Principal Secretary to Government Industries and Commerce

 

 

Cordico Announces Exclusive Partnership With ‘Emotional Survival’ Author Dr. Kevin Gilmartin

Cordico is the exclusive technology partner of famous speaker and bestselling author of ‘Emotional Survival for Law Enforcement: A Guide for Officers and Their Families’

GOLD RIVER, California, Aug 4, 2020Cordico is proud to announce an exclusive partnership with Dr. Kevin Gilmartin, author of "Emotional Survival for Law Enforcement: A Guide for Officers and Their Families." Dr. Gilmartin’s worldwide bestselling book has sold millions of copies and is widely considered to be the most influential book ever written on the topic of officer wellness.

Dr. Kevin Gilmartin is the author of 'Emotional Survival for Law Enforcement: A Guide for Officers and Their Families.'
Dr. Kevin Gilmartin is the author of ‘Emotional Survival for Law Enforcement: A Guide for Officers and Their Families.’

"Everyone at Cordico is honored to be working with Dr. Gilmartin," said Dr. David Black, CEO of Cordico. "We’re preserving his legacy for future generations of first responders and making his knowledge, wisdom, and winning presentations more accessible than ever before through our technology platforms. Fortunately, our cloud-based platforms will enable us to meet the worldwide demand for his Emotional Survival strategies, which will allow us to help more people serving in the most critical roles than ever before."

Dr. Gilmartin’s Emotional Survival digital content, including videos, writings, and more will be available exclusively within the Cordico Wellness Apps and an interactive Emotional Survival eLearning platform being designed by Cordico in partnership with Dr. Gilmartin.

"Dr. Gilmartin is a legend amongst law enforcement and has helped save countless lives, families, and careers," said Dr. Black. "He is the number one speaker and author in the field of officer wellness and we could not be more excited about our partnership and all we will be doing together to help support first responders."

About Dr. Kevin Gilmartin

Dr. Gilmartin is a behavioral scientist specializing in law enforcement and public safety related issues. He is the author of the book "Emotional Survival for Law Enforcement: A Guide for Officers and Their Families." He previously spent 20 years working in law enforcement and supervised the Hostage Negotiations Team and the Behavioral Sciences Unit. He is a former recipient of the International Association of Chiefs of Police-Parade Magazine, National Police Officer Citation Award for contributions during hostage negotiations. He presently maintains a consulting relationship with public safety and law enforcement agencies in the U.S., Canada and Australia. The Department of Justice, FBI, Royal Canadian Mounted Police, New South Wales Police and International Association of Chiefs of Police have published his work. He holds a doctoral degree in Clinical Psychology from The University of Arizona and is a veteran of the U.S. Marine Corps.

About Cordico

Cordico is the world leader in wellness technology for high-stress professions, providing trusted, confidential, 24/7 proactive and preventative wellness support specially developed for law enforcement and others serving in the most demanding and critical roles. Our customized, continuously updated wellness platform solutions provide hand-held access to valuable resources including anonymous self-assessments, instructional videos, peer support services, and on-demand tools targeting behavioral and emotional health, physical fitness, resilience, and much more. https://www.cordico.com

Media Contact: 
Kevin Dacy
Phone: 844.CORDICO (1.844.267.3426)
Email: info@cordico.com

Related Images

cordico-is-the-exclusive-digital.jpg
Cordico is the Exclusive Digital Partner of Dr. Kevin Gilmartin
Dr. Kevin Gilmartin is the author of ‘Emotional Survival for Law Enforcement: A Guide for Officers and Their Families.’

Related Links

Visit Cordico

Photo – https://techent.tv/wp-content/uploads/2020/08/cordico-announces-exclusive-partnership-with-emotional-survival-author-dr-kevin-gilmartin.jpg

Related Links :

Cordico Home

/C O R R E C T I O N — Infineon/


In the news release, "Accurate, anonymous, contactless: Infineon’s radar-based entrance counter solution for public buildings, retail stores, restaurants or corporate spaces", issued on July 28, 2020 by Infineon over PR Newswire, we are advised by the company that the dimension of the discrete rada board mentioned in the first paragraph should be 20mm x 15 mm instead of 250mm x 150 mm, corrected release follows:

Accurate, anonymous, contactless: Infineon’s radar-based entrance counter solution for public buildings, retail stores, restaurants or corporate spaces

MUNICH, July 31, 2020 — Governmental regulations all over the world created an urgent need for solutions to secure social distancing in public buildings in order to support slowing down the spread of Covid-19. Within three months, Infineon Technologies AG (FSE: IFX / OTCQX: IFNNY) developed a solution that counts people while entering and leaving buildings or rooms and ensures social distancing at the same time. The Smart entrance counter solution is a miniaturized, discrete radar board (20 mm x 15 mm) that accurately and anonymously counts people with one single 60 GHz radar sensor and integrated software. A traffic light system informs about if an entry is allowed or not.

The smart entrance counter solution is a miniaturized, discrete radar board (20 mm x 15 mm) that accurately and anonymously counts people with one single 60 GHz radar sensor and integrated software.
The smart entrance counter solution is a miniaturized, discrete radar board (20 mm x 15 mm) that accurately and anonymously counts people with one single 60 GHz radar sensor and integrated software.

 

"We aimed at quickly creating an effective solution that allows everyone of us to securely move within public spaces, in offices, airports or restaurants according to the regulations of the so-called new normal," says Andreas Urschitz, Division President Power & Sensor Systems Infineon Technologies. "Our Smart entrance counter solution is a closed system. On the one hand, it prevents overcrowding, on the other hand, it enables businesses to keep their operations running. And most importantly, due to the use of radar technology, personal data are 100 percent protected. The system counts a person, but does not know who it is."

The expected volume for this kind of solution amounts to 90 million units globally. Infineon’s Smart entrance counter solution with XENSIV™ 60 GHz radar sensor works contactlessly and can easily be installed on the side or ceiling of an entrance or exit. It can be implemented in all kinds of building types, such as public buildings, retail and grocery stores, restaurants, schools or corporate spaces, e.g. canteens, offices, and the like. Furthermore, Infineon is already working on the next generation that will include further features.

Availability
The Smart entrance counter solution (KIT BGT60TR13C EMBEDD) with integrated software is available now for evaluation. The second generation will be available in September 2020. For more information: www.infineon.com/smart-entrance

Photo – https://photos.prnasia.com/prnh/20200728/2869180-1?lang=0
Logo – https://photos.prnasia.com/prnh/20200707/2850283-1LOGO?lang=0

111 to Announce Second Quarter 2020 Unaudited Financial Results on August 20, 2020

SHANGHAI, July 31, 2020 — 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a Company dedicated to digitally connecting patients with drugs and healthcare services in China, today announced that it will report its unaudited financial results for the second quarter ended June 30, 2020, before the U.S. market opens on Thursday, August 20, 2020.

111’s management team will host an earnings conference call at 7:30 AM U.S. Eastern Time on Thursday, August 20, 2020 (7:30 PM Beijing Time on the same day).

Details for the conference call are as follows:

Event Title:                       

111, Inc. Second Quarter 2020 Earnings Conference Call

Registration Link:            

http://apac.directeventreg.com/registration/event/7482148

All participants must use the link provided above to complete the online registration process in advance of the conference call. Upon registering, each participant will receive a set of participant dial-in numbers, the Direct Event passcode, and a unique Registration ID, which can be used to join the conference call.

Please dial in 15 minutes before the call is scheduled to begin and provide the Direct Event passcode and unique Registration ID you have received upon registering to join the call.

A telephone replay of the call will be available after the conclusion of the conference call until August 28, 2020, 09:59 P.M. ET on:

United States:                    

+1-855-452-5696

International:                      

+61-2-8199-0299

Conference ID:                   

7482148

A live and archived webcast of the conference call will be available on the Investor Relations section of 111’s website at http://ir.111.com.cn/.

About 111, Inc.

111, Inc. (NASDAQ: YI) ("111" or the "Company") is a Company dedicated to digitally connecting patients with drugs and healthcare services in China. The Company provides hundreds of millions of consumers with better access to pharmaceutical products and medical services directly through its online retail pharmacy and indirectly through its offline pharmacy network. 111 also offers online medical services through its internet hospital, 1 Clinic, which provides consumers with cost-effective and convenient online consultation and electronic prescription services. In addition to providing direct services to consumers through its online retail pharmacy, 111 also enables offline pharmacies to better serve their customers.  The Company’s online wholesale pharmacy, 1 Drug Mall, serves as a one-stop shop for pharmacies to source a vast selection of pharmaceutical products. The Company’s New Retail platform, by integrating the front and back ends of the pharmaceutical supply chain, has formed a smart supply chain, which transforms the flow of pharmaceutical products to pharmacies and modernizes how they serve their customers.

For more information on 111, please visit: http://ir.111.com.cn/.

For more information, please contact:

111, Inc.
Investor Relations
Email: ir@111.com.cn

111, Inc.
Media Relations 
Email: press@111.com.cn 
Phone: +86-021-2053 6666 (China)

GCM Strategic Communications
IR Counsel
Email: 111.ir@gcm.international

Related Links :

http://www.yiyaowang.com

DoctorxDentist Identifies The Top 10% of Doctors in Singapore

Patients are 65% more likely than they were prior to the onset of coronavirus to choose a healthcare provider based on the quality of care they will receive, according to the COVID-19 Patient Confidence Study.

SINGAPORE, July 30, 2020DoctorxDentist, the leading online resource for information about doctors in Singapore, today released its 2020 analysis of best performing physicians. 

“The goal of the DxD10 Trusted Reviews Award is to acknowledge physicians who are consistently highly rated” said Tristan Hahner, CEO of DoctorxDentist. “As healthcare gets more complicated and more choices for care become available, it’s important to provide information that helps consumers easily identify providers who make patient experience a top priority. This is our way of recognizing physicians for their commitment to outstanding care, based on opinions of those who know them best – their patients.”

DxD10 Trusted Reviews Award Recognizes Outstanding Healthcare Providers, Based on Patient Feedback

Each year, only 10% of doctors in Singapore are named a DxD10 Trusted Reviews Award recipient. DoctorxDentist evaluated the performance of 10,112 doctors and dentists nationwide by compiling and analyzing thousands of ratings and reviews of patients from across Singapore and Southeast Asia. The evaluation found that:

  • Winners had an average of 22 reviews, while the average doctor in Singapore had less than 5 reviews.
  • Award recipients maintained an average rating of 4.5 or higher out of a 5-star rating system.
  • Doctors with a minimum rating of 4.5 stars get seven times as many appointments as doctors with a rating less than 4.5 stars.
  • Doctors with at least 5 reviews get 74% of online appointments.
  • Reviews most often mentioned a doctor’s clinical skill or bedside manner. 
Dr Marlene Teo from An Dental Clinic, recipient of DxD10 Trusted Reviews Award for 2020.
Dr Marlene Teo from An Dental Clinic, recipient of DxD10 Trusted Reviews Award for 2020.

“It’s been my dream to help patients demystify dental issues,” said Dr Marlene Teo, an award recipient. “I’m really honored to receive the ‘DxD10 Trusted Reviews Award’ as an affirmation that we are building trust and rapport with our patients.”

About DoctorxDentist

DoctorxDentist.com is the fastest-growing doctor discovery platform in Singapore and South East Asia. Millions of consumers each year find and schedule appointments with their provider of choice at DoctorxDentist.

By enhancing each touchpoint in the patient journey — from the first impression online, to appointment booking and review harvesting post-appointment — DoctorxDentist makes it easy for healthcare providers to attract more patients, manage online reputation and modernize the patient experience. Learn more about how physicians partner with DoctorxDentist

Photo – https://photos.prnasia.com/prnh/20200723/2865644-1?lang=0

Related Links :

https://www.doctorxdentist.com

DriWay Technologies Commences Bomb Shelter Pilot Project with Korean Government

The Daejeon City Government will use DriWay’s dehydration devices, starting in a key bomb shelter, to remove invasive moisture and improve air safety.

NEW YORK, July 29, 2020 — The Republic of Korea’s Daejeon City Government has commissioned DriWay Technologies to install its dehydration devices in the city’s bomb shelters, to reduce the invasive moisture within the structures. This partnership begins with a three-month pilot project in the Dunsan Fire Station bomb shelter, with installation to take place the first week of August 2020.

South Korea maintains approximately 19,000 bomb shelters throughout the country for civilian use in an emergency, such as potential missile attacks from North Korea. Many such shelters are located within structures like fire stations.

Daejeon, the country’s fifth largest metropolis, has declared its commitment to ensuring that the air quality in these bunkers is safe and healthy for its citizens. Upon encountering invasive building moisture that obstructed a summer 2020 renovation project in the Dunsan Fire Station, Daejeon city leaders initiated a partnership with DriWay to address the problem using DriWay’s dehydration devices.

DriWay’s patented technology naturally breaks the attraction that causes groundwater to rise into buildings, allowing a combination of evaporation and gravity to remove excess water from the walls. Without requiring any potentially hazardous chemicals or electrical power, it provides a sustainable, permanent, and environmentally friendly solution for building owners, managers, and occupants.

“The leadership of Daejeon, including Construction Department Chief Kim Jong Shin, have shown admirable dedication to the security and wellbeing of the people they serve. It is an honor for us to be entrusted with something as important as keeping the air within these bunkers safe and healthy for the city’s residents,” said Steve Kim, COO of DriWay Korea.

“We are proud to serve the city of Daejeon and help protect its residents by providing them with better air quality in its shelters,” said Roy Judelson, Global Chairman and CEO of DriWay Technologies. “These shelters are critical for keeping residents of South Korea safe from outside harm, and our priority is to support Daejeon’s leadership in also keeping residents safe from health hazards caused by invasive moisture inside the shelters.”

About DriWay Technologies
DriWay Technologies is a building health technology company that addresses the environmental and health hazards caused by invasive moisture: mold-causing ground moisture that naturally enters building foundations, basements, and ground floors and can inflict health risks, structural damage, and increased thermal insulation costs. This problem plagues 10% of buildings in the US, and higher percentages in other regions of the world, according to a 2019 EY market study.

DriWay is headquartered in London, with subsidiaries in the US, UK, UAE, and South Korea. It is currently providing its services to the US Government and marquee clients such as Grosvenor Group in London, Nakheel Properties in Dubai, Olshan Properties in New York City, and Hyundai Corporation in South Korea. In the next year, DriWay will also be expanding its operations into India, Japan, Indonesia, Greece, and Cyprus after recently completing a Seed Round financing at a $100 million valuation.

For all media inquiries, please contact media@driway.com.

Global Healthcare Interoperability Market to Witness Nearly Two-fold Growth by 2024

Data interoperability and data analytics are key contributors to global market revenue for healthcare interoperability, says Frost & Sullivan

SANTA CLARA, California, July 27, 2020 — Frost & Sullivan’s recent analysis, Global Healthcare Interoperability Market, Forecast to 2024, contends that interoperability has become a critical consideration for all health IT (HIT) applications. Countries where HIT interoperability standards are equally important and regulated are projected to drive the market, registering near-double-digit growth. The buoyant market for global healthcare interoperability is expected to grow at a compound annual growth rate (CAGR) of 13.8%, reaching $7.96 billion by 2024 from $4.17 billion in 2019.

Global Healthcare Interoperability Market to Witness Nearly Two-fold Growth by 2024
Global Healthcare Interoperability Market to Witness Nearly Two-fold Growth by 2024

For further information on this analysis, please visit: http://frost.ly/49u.

“With the advent of innovative delivery models and shifting focus on value-based care, the demand for interoperable systems will continue to grow,” said Koustav Chatterjee, Transformational Health Principal Analyst at Frost & Sullivan. “Additionally, the ability to achieve medical device connectivity across the care continuum will be critical. Real-time integration of accurate patient-generated data from connected apps and systems into a central command center platform that uses cognitive algorithms to automate care coordination and personalize intervention will be a key competitive advantage during and post-COVID-19.”

Chatterjee added: “From product segment perspectives, data interoperability and data analytics will primarily dominate the global healthcare data interoperability market. Both of these solution segments are expected to contribute more than 90% of the global market revenue throughout the study period. Further, application program interface (API) integration is the third-most important solution segment contributing to global market revenue, followed by data cleansing, data integration, and application integration.”

Globally, major government agencies are mandating healthcare stakeholders to comply with national healthcare data interoperability standards. This is resulting in higher adoption of HIT applications, thereby presenting immense growth opportunities for vendors involved in healthcare interoperability, including:

  • API Management: Vendors are encouraged to create API partnership platforms to achieve cross-continuum connectivity.
  • Data Management: Cloud or on-premise data centers comprise actionable healthcare intelligence, indicative of a past pattern of diseases, payment frauds, and operational inefficiencies.
  • Electronic Medical Record (EMR) Partnerships: Build the EMR interoperability consulting services business line.
  • Medical Device Partnerships: Utilize real-time assessment of patient-generated data by care episodes and patient population.
  • Health Information Exchange: Develop a central infrastructure to enable the delivery of actionable health data.

Global Healthcare Interoperability Market, Forecast to 2024, is the latest addition to Frost & Sullivan’s Transformational Health research and analyses available through the Frost & Sullivan Leadership Council, which helps organizations identify a continuous flow of growth opportunities to succeed in an unpredictable future.

About Frost & Sullivan

For over five decades, Frost & Sullivan has become world-renowned for its role in helping investors, corporate leaders and governments navigate economic changes and identify disruptive technologies, Mega Trends, new business models and companies to action, resulting in a continuous flow of growth opportunities to drive future success. Contact us: Start the discussion.

Global Healthcare Interoperability Market, 2019–2024

K418

Contact:
Mariana Fernandez
Corporate Communications
P: +1 (210) 348.1012
E: mariana.fernandez@frost.com 
https://www.frost.com

Photo – https://mma.prnasia.com/media2/1219817/interoperability_healthcare.jpg?p=medium600

Related Links :

http://www.frost.com